Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/21/2025

Management of Hypoglycemia During PET-CT Preparation

Blood Glucose Monitoring Requirements

  • The European Journal of Nuclear Medicine and Molecular Imaging recommends checking blood glucose upon patient arrival at the imaging center to identify levels that are too low (below 4 mmol/L or 70 mg/dL) or too high, avoiding unnecessary waiting time 1, 3, 4, 5
  • A calibrated glucometer or bedside glucose measurement device should be used for screening purposes 1, 6
  • Blood glucose must be measured again immediately prior to FDG administration 1, 3, 4

Immediate Treatment Protocol for Hypoglycemia

  • For conscious patients who can swallow, administer 15-20 grams of oral glucose in the form of dextrose tablets as first-line treatment, and recheck blood glucose every 15 minutes, repeating treatment until glucose returns to ≥70 mg/dL 2, 7
  • If dextrose tablets are not available, alternatives containing at least 15 grams of simple sugars can be used, such as 1 tablespoon table sugar, 6-8 oz apple or orange juice, 6-8 oz regular soda, 1 tablespoon honey, or 15-25 jellybeans, gummy bears, or hard-shelled candies 2

Timing Considerations for PET-CT Scanning

  • Delay FDG injection until blood glucose is ≥4 mmol/L (70 mg/dL) to ensure adequate scan quality and patient safety 1, 3, 4, 5
  • The upper acceptable limit for clinical PET-CT is <11 mmol/L (200 mg/dL) 1, 3, 4

Special Considerations for Diabetic Patients

  • For patients with type 1 diabetes, continue prescribed daily insulin doses when consuming meals, avoid short-acting insulin 4-6 hours before the study, and use sliding-scale insulin during meal preparation but avoid it on the day of the study 8, 5
  • For patients with type 2 diabetes, stop oral hypoglycemic medications during the fasting period, hold the morning dose, and avoid taking insulin 4-6 hours before the study 7, 8

Critical Pitfalls to Avoid

  • Never proceed with FDG injection when glucose is <4 mmol/L (70 mg/dL), as this compromises both patient safety and scan quality 1, 3, 4, 5
  • Avoid administering insulin to correct hyperglycemia without adequate monitoring, as this may precipitate hypoglycemia 8

Post-Treatment Protocol

  • Continue monitoring glucose levels to ensure stability before administering FDG 1, 6
  • Document the hypoglycemic episode and glucose values for the medical record 6

REFERENCES

1

fdg pet/ct: eanm procedure guidelines for tumour imaging: version 2.0. [LINK]

European Journal of Nuclear Medicine and Molecular Imaging, 2015

2

fdg pet/ct: eanm procedure guidelines for tumour imaging: version 2.0. [LINK]

European Journal of Nuclear Medicine and Molecular Imaging, 2015

3

fdg pet/ct: eanm procedure guidelines for tumour imaging: version 2.0. [LINK]

European Journal of Nuclear Medicine and Molecular Imaging, 2015

4

fdg pet/ct: eanm procedure guidelines for tumour imaging: version 2.0. [LINK]

European Journal of Nuclear Medicine and Molecular Imaging, 2015

5

fdg pet/ct: eanm procedure guidelines for tumour imaging: version 2.0. [LINK]

European Journal of Nuclear Medicine and Molecular Imaging, 2015

6

Treatment of Hypoglycemia with Dextrose [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

7

Managing Hypoglycemia to Reduce Ischemic Risk in Diabetic Patients [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025